步长制药:控股股东步长(香港)新增质押760万股

Core Viewpoint - The announcement reveals that the controlling shareholder of the company, Buchang (Hong Kong), holds 490,957,202 shares, representing 46.56% of the total shares, with a total of 108,530,000 shares pledged, which accounts for 22.11% of their holdings and 10.29% of the total share capital [1] Summary by Relevant Sections - Shareholding Structure - The controlling shareholder holds 490,957,202 shares, which is 46.56% of the total shares [1] - The total shares pledged by the controlling shareholder amount to 108,530,000, representing 22.11% of their holdings and 10.29% of the total share capital [1] - Pledge Details - An additional 7,600,000 shares have been pledged, with 3,600,000 shares pledged to CITIC Bank Jinan Branch and 4,000,000 shares pledged to CITIC Financial Leasing Co., Ltd [1] - The pledge start date for these shares is December 29, 2025, and the maturity date for the latter pledge is December 30, 2028 [1] - Overall Shareholding and Pledge Status - The controlling shareholder and their concerted parties collectively hold 598,200,660 shares, which is 56.72% of the total shares [1] - The total pledged shares by the controlling shareholder and concerted parties amount to 108,530,000, accounting for 18.14% of their holdings and 10.29% of the total share capital [1]

BUCHANG PHARMA-步长制药:控股股东步长(香港)新增质押760万股 - Reportify